ImmuSmol

Business Data, Corporate Office and Headquarter Address

About

ImmuSmol is Biotechnology in France that focus on therapeutic applications business. Founded in 2012. They cover business area such as developer, small molecule antibody, tumor, diagnostic and therapeutic application, healthcare professional, visualization, quantification, modulation, monoclonal antibody, endogenous small molecule, cancer, CNS disorder.

Business Type

Biotechnology

Country

France

Founded

2012
( 12 years old in 2024 )

Company Focus

Therapeutic Applications

Website

-

Corporate Office and Headquarter Office address:

PTIB - Hôpital Xavier Arnozan
Avenue Haut Lévêque
33600 Pessac
France

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developersmall molecule antibodytumordiagnostic and therapeutic applicationhealthcare professionalvisualizationquantificationmodulationmonoclonal antibodyendogenous small moleculecancerCNS disorder

* We use standard office opening hours in near ImmuSmol's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

ImmuSmol Frequently Asked Questions

What or who is ImmuSmol?

ImmuSmol is Biotechnology business from France that founded in 2012 (12 years old in 2024), ImmuSmol business is focusing on Therapeutic Applications.

Where is ImmuSmol headquarter and corporate office address?

ImmuSmol headquarter office and corporate office address is located in PTIB - Hôpital Xavier Arnozan Avenue Haut Lévêque 33600 Pessac France.

Where is ImmuSmol country origins?

ImmuSmol was founded in France.

What is Therapeutic Applications business focus on?

In 2024, ImmuSmol is currently focus on therapeutic applications sector.

Therapeutic Applications Business Interest from Google Trend

Above is snippet of Google Trends for "therapeutic applications" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with ImmuSmol, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.